Senseonics SENS recently announced the full availability of its long-term, implantable Continuous Glucose Monitoring (CGM) ...

The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.

FAYETTEVILLE, GA, UNITED STATES, February 15, 2026 /EINPresswire.com/ -- Continuous glucose monitoring is essential for ...

MALVERN, PA — LifeScan announced a partnership with biosensor company i-SENS to launch a continuous glucose monitoring system under the OneTouch Vita brand, with an initial rollout planned in several ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February ...